Naloxone Alleviate the Severity of Delirium in Hospitalized Patients With Parkinsonism: Three Case Reports
Purpose: Delirium is common in geriatric with Parkinson's disease (PD). Treatments for delirium have generally been neuroleptics; however, antipsychotics have potential effect to block striatal dopamine D2 receptors and worsen symptom of parkinsonism. We explored whether naloxone can alleviate...
Main Authors: | Haiyan Jin, Jie Zhang, Qiongyue Hu, Junjiao Ping, Tingyun Jiang, Baoguo Du, Xin Duan |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-10-01
|
Series: | Frontiers in Psychiatry |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fpsyt.2021.748958/full |
Similar Items
-
Delirium due to Anticholinergic Intoxication and Use of Physostigmine in Pediatric Emergency Room
by: Alper Çiçek, et al.
Published: (2022-04-01) -
The recent guidelines for pharmacotherapy of Parkinson’s Disease
by: Karabin Tomasz, et al.
Published: (2022-08-01) -
Cognitive disorders in advanced Parkinson’s disease: challenges in the diagnosis of delirium
by: Christine Daniels, et al.
Published: (2024-03-01) -
The effect of the anticholinergic burden on duration and severity of delirium in older hip‐surgery patients with and without haloperidol prophylaxis: A post hoc analysis
by: Monique P. H. Tillemans, et al.
Published: (2021-12-01) -
Delirium Induced by Quetiapine and the Potential Role of Norquetiapine
by: Filipe Almeida, et al.
Published: (2019-08-01)